ARTICLE | Clinical News
Boostrix regulatory update
July 18, 2011 7:00 AM UTC
FDA approved an sBLA for GlaxoSmithKline's Boostrix to prevent tetanus, diphtheria and pertussis in subjects ages >=65 years. The tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tda...